 19 PM / in 6 minutes BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer Reuters Staff 1 Min Read 
Jan 24 (Reuters) - Angiodynamics Inc: 
* ANGIODYNAMICS RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE NANOKNIFE® SYSTEM FOR THE TREATMENT OF STAGE III PANCREATIC CANCER 
* ANGIODYNAMICS INC - ‍FDA GRANTED EXPEDITED ACCESS PATHWAY DESIGNATION TO COMPANY‘S NANOKNIFE SYSTEM​ Source text for Eikon: Further company coverage: